Espire Hospi

Why is Espire Hospitality Ltd falling/rising?

As of 13-Aug, the stock price of Espire Hospitality Ltd has risen slightly by 0.28% to 162.90, following a trend reversal after two days of decline. However, it remains significantly underperforming with a year-to-date decline of 45.23% and a new 52-week low of Rs. 156.05, indicating ongoing challenges and reduced investor interest.

As of 13-Aug, the stock price of Espire Hospitality Ltd is rising slightly, with a change of 0.45 (0.28%) to a current price of 162.90. This increase follows a trend reversal after two consecutive days of decline. However, it is important to note that the stock has recently hit a new 52-week low of Rs. 156.05 earlier today, indicating ongoing challenges.<BR><BR>Despite the slight uptick in price, the stock has been underperforming over various periods, with a year-to-date decline of 45.23% and a one-year drop of 73.38%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bearish trend. <BR><BR>Investor participation has also decreased significantly, with delivery volume falling by 86.41% against the 5-day average, indicating reduced interest from investors. Overall, while there is a minor rise in the stock price today, the broader context shows significant challenges and a lack of strong positive momentum.

Which are the latest news on Espire Hospi?

When is the next results date for Espire Hospitality Ltd?

The next results date for Espire Hospitality Ltd is 14 August 2026.

The next results date for Espire Hospitality Ltd is scheduled for 14 August 2026.

Should I buy, sell or hold Espire Hospitality Ltd?

How big is Espire Hospi?

As of 10th June, Espire Hospitality Ltd has a market capitalization of 306.00 Cr, with recent net sales of 132.21 Cr and a net profit of 8.40 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Espire Hospitality Ltd has a market capitalization of 306.00 Cr, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 132.21 Cr, while the sum of Net Profit for the same period is 8.40 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 43.51 Cr, and Total Assets amount to 181.20 Cr.

Who are in the management team of Espire Hospi?

The management team of Espire Hospi includes Gagan Oberoi (Chairperson), Prithvi Raj Singh (Managing Director), Leela Rani Bisht, Amit Rai (Directors), Sumeer Narain Mathur (CFO & Company Secretary), and independent directors Pramod Bhatnagar, Dileep Kumar, and Amit Kumar Jain. They oversee the company's operations and strategic direction.

The management team of Espire Hospi includes the following individuals:<BR><BR>1. **Gagan Oberoi** - Chairperson<BR>2. **Prithvi Raj Singh** - Managing Director<BR>3. **Leela Rani Bisht** - Director<BR>4. **Amit Rai** - Director<BR>5. **Sumeer Narain Mathur** - CFO & Company Secretary<BR>6. **Pramod Bhatnagar** - Independent Director<BR>7. **Dileep Kumar** - Independent Director<BR>8. **Amit Kumar Jain** - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction. If you have any more questions about Espire Hospi or its management, feel free to ask!

Are Espire Hospitality Ltd latest results good or bad?

Espire Hospitality Ltd's latest Q4 FY26 results show mixed outcomes, with record revenue of ₹42.67 crores but a significant 48.48% drop in net profit to ₹4.22 crores and a decline in operating margins, indicating serious operational challenges and high debt levels. Overall, the results are more concerning than favorable, suggesting caution for investors.

Espire Hospitality Ltd's latest results for Q4 FY26 present a mixed picture, but overall, they lean towards the negative side. While the company achieved its highest-ever quarterly revenue of ₹42.67 crores, this was overshadowed by a significant decline in profitability. The net profit dropped sharply by 48.48% quarter-on-quarter to ₹4.22 crores, and the operating margin fell dramatically from 35.73% to 11.48%. <BR><BR>This decline in profitability despite revenue growth indicates serious operational challenges. The company's reliance on non-operating income, which constituted a large portion of its profit before tax, raises concerns about the sustainability of its reported earnings. Additionally, the high debt burden, reflected in a debt-to-equity ratio averaging 8.60 times, adds further pressure on its financial stability.<BR><BR>In summary, while revenue growth is a positive sign, the substantial drop in net profit and operating margins, coupled with high leverage and dependence on non-core income, suggest that the results are more concerning than favorable. Investors should approach the company with caution given these factors.

Who are the peers of the Espire Hospi?

Espire Hospi's peers include Sinclairs Hotels, Sayaji (Indore), Robust Hotels, and Apollo Sindoori, among others. Espire Hospi has below-average management and growth ratings, with a 1-year return of -57.56%, the lowest among its peers.

Peers: The peers of Espire Hospi are Sinclairs Hotels, Sayaji (Indore), Robust Hotels, Asian Hotels (E), Sayaji Hot. Pune, Emerald Leisures, Graviss Hospital, Grand Continent, and Apollo Sindoori.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sinclairs Hotels and Sayaji Hot. Pune, while Good management risk is found at Grand Continent. Average management risk is noted at Asian Hotels (E), and Below Average management risk is present at Sayaji (Indore), Robust Hotels, Espire Hospi, Graviss Hospital, and Apollo Sindoori. For Growth, Excellent growth is seen at Sinclairs Hotels and Apollo Sindoori, while Good growth is found at Robust Hotels and Grand Continent. Below Average growth is noted at Sayaji (Indore), Asian Hotels (E), Sayaji Hot. Pune, and Espire Hospi, and the rest have either does not qualify or are not specified. Capital Structure ratings show Excellent at Sinclairs Hotels and Sayaji Hot. Pune, Good at Graviss Hospital and Grand Continent, and Below Average at Robust Hotels, Espire Hospi, Asian Hotels (E), and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sayaji (Indore) at -9.70%, while Espire Hospi has the lowest at -57.56%, indicating a significantly poorer performance compared to its peers. Additionally, several peers including Robust Hotels, Graviss Hospital, and Emerald Leisures have negative six-month returns.

What does Espire Hospi do?

Espire Hospitality Ltd operates in the Hotels & Resorts industry, with a market cap of INR 306 Cr and reported net sales of 41 Cr and net profit of 8 Cr for December 2025. The company, formerly known as Wellesley Corporation Limited, was incorporated in 1991 and rebranded in 2022.

Overview:<BR>Espire Hospitality Ltd operates in the Hotels & Resorts industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in October 1991 and was formerly known as Wellesley Corporation Limited until its name change on January 17, 2022. The latest reported quarterly results are for December 2025, showing net sales and profit.<BR><BR>Financial Snapshot:<BR>Net Sales: 41 Cr (Quarterly Results - Dec 2025)<BR>Net Profit: 8 Cr (Quarterly Results - Dec 2025)<BR>Market Cap: INR 306 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 37.00<BR>Industry P/E: 26<BR>Dividend Yield: 0.00%<BR>Debt Equity: 3.18<BR>Return on Equity: 21.44%<BR>Price to Book: 7.92<BR><BR>Contact Details:<BR>Address: Shop No 1 Country Inn, Mehragaon Bhimtal UTT : 248179<BR>Tel: 91-011-2618 4535/2618 4411<BR>Email: investor@wellesleycorp.com<BR>Website: http://www.espirehospitality.com

Is Espire Hospi overvalued or undervalued?

As of November 20, 2025, Espire Hospi is considered overvalued with a PE ratio of 169.37, significantly higher than its peers, and despite impressive long-term returns, it has recently underperformed compared to the Sensex.

As of 20 November 2025, the valuation grade for Espire Hospi has moved from very expensive to expensive, indicating a slight improvement but still suggesting high valuation concerns. The company is currently considered overvalued based on its elevated financial ratios, including a PE ratio of 169.37, an EV to EBITDA of 28.88, and a PEG ratio of 70.04, which are significantly higher than industry norms.<BR><BR>In comparison to its peers, Espire Hospi's PE ratio far exceeds that of JSW Steel at 46.74 and Tata Steel at 28.92, both of which are rated as fair and attractive, respectively. This stark contrast highlights the overvaluation of Espire Hospi in the current market. Additionally, while the company has shown impressive returns over the past few years, including a staggering 2495.27% over three years, its recent performance has lagged behind the Sensex, with a 1-month return of -22.85% compared to the Sensex's 1.50%.

Is Espire Hospi technically bullish or bearish?

As of November 17, 2025, the market trend is bearish with moderate strength, supported by bearish indicators from the MACD, moving averages, and Bollinger Bands, despite some bullish momentum in the RSI.

As of 17 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm a bearish outlook. The weekly Bollinger Bands also indicate a bearish trend, while the KST is bearish on the weekly timeframe. Although the weekly RSI shows bullish momentum, it is not sufficient to counter the overall bearish indicators. The Dow Theory indicates no trend on the weekly level and mildly bearish on the monthly level, further supporting the bearish stance.

How has been the historical performance of Espire Hospi?

Espire Hospi has shown significant growth from March 2022 to March 2025, with net sales increasing from 1.69 Cr to 119.55 Cr, and profitability improving with profit after tax rising to 8.27 Cr from a loss. The company's total assets and equity reserves also expanded notably during this period.

Answer:<BR>The historical performance of Espire Hospi shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Espire Hospi's net sales have increased dramatically from 1.69 Cr in March 2022 to 119.55 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, reaching 119.55 Cr in March 2025, up from just 1.69 Cr in March 2022. The company has also improved its operating profit, which turned positive in March 2022 and rose to 23.08 Cr by March 2025. Profit before tax also saw a notable increase, moving from a mere 0.03 Cr in March 2022 to 10.81 Cr in March 2025, while profit after tax reached 8.27 Cr in March 2025, compared to a loss of 0.08 Cr in March 2022. The company's total assets grew significantly from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, reflecting a robust expansion. Total liabilities also increased, from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, primarily driven by long-term borrowings which rose to 69.93 Cr. Despite the increase in liabilities, the company's equity capital and reserves improved, with reserves turning positive at 28.58 Cr in March 2025, up from negative values in previous years. Overall, Espire Hospi's financial performance indicates a strong growth trajectory with improving profitability and asset base.

Who are the top shareholders of the Espire Hospi?

The top shareholders of Espire Hospi are primarily the promoters, with Mrs. Sadhana Rai holding 67.01%. Other significant shareholders include Rajesh Kumar Gupta at 6.96%, individual investors with 18.5%, and a foreign institutional investor with 2.08%.

The top shareholders of Espire Hospi include the promoters, with Mrs. Sadhana Rai holding the largest share at 67.01%. There are no pledged promoter holdings. Additionally, Rajesh Kumar Gupta is the highest public shareholder, owning 6.96%. The company also has individual investors holding a combined 18.5%, and there is one foreign institutional investor (FII) that holds 2.08%. Overall, the majority of the shares are held by the promoters.

Has Espire Hospi declared dividend?

No Dividend History Available